Retrieve available abstracts of 192 articles: HTML format
Single Articles
May 2025
PARIKH AK, Forman CA, Lipner SR Ethical considerations of treating melanoma anxiety in patients with
obsessive-compulsive disorder.
J Am Acad Dermatol. 2025 May 5:S0190-9622(25)00720. PubMed
HAN Z, Hou J, Chang M Global Inequalities in the Burden of Melanoma From 1990 to 2021: Findings From
the Global Burden of Disease Study 2021.
J Am Acad Dermatol. 2025 May 3:S0190-9622(25)00690. PubMed
April 2025
KASHERI E, Sa B, Kraft G, Vattigunta M, et al Mapping Melanoma Mortality Hot Spots: A Geographic Spatial Analysis of
Socioeconomic and Provider Disparities.
J Am Acad Dermatol. 2025 Apr 25:S0190-9622(25)00680. PubMed
MAI JZ, Sargen MR, Linet MS, Ike E, et al Impact of personal sun sensitivity and UV radiation on the association between
blistering sunburns and melanoma.
J Am Acad Dermatol. 2025 Apr 25:S0190-9622(25)00683. PubMed
SCHONMANN Y, Cohen NT, Czarnowicki T Evaluating cancer risk in a large cohort of 25,008 patients with vitiligo:
Insights from a comprehensive cohort population-based study.
J Am Acad Dermatol. 2025;92:741-752. PubMedAbstract available
March 2025
FAN X, Zhao Y, Zhao X Optimizing Melanoma Biopsy Practices: Implications for Clinical Accuracy and
Patient Outcomes.
J Am Acad Dermatol. 2025 Mar 29:S0190-9622(25)00553. PubMed
KHATTAB S, Beagles E, Tran M, Moseley C, et al Clinicopathologic Attributes and Downstream Outcomes of Mucosal Melanomas: A
Multi-Hospital Cohort Study.
J Am Acad Dermatol. 2025 Mar 28:S0190-9622(25)00548. PubMed
MUNJAL A, Loeffler B, Fitzhugh M, Mani S, et al The impact of rurality and hospital proximity on melanoma staging during
COVID-19: A retrospective cohort study.
J Am Acad Dermatol. 2025 Mar 23:S0190-9622(25)00529. PubMed
ADIGBLI G, Reed B, Khera B, Sangha M, et al Tumor-Infiltrating Lymphocyte Scoring Improves Progression Risk Prediction in
Stage II Melanoma: A Retrospective Cohort Study.
J Am Acad Dermatol. 2025 Mar 21:S0190-9622(25)00509. PubMedAbstract available
TAYLOR MA, Sharma D, Fagan E, Ituarte B, et al Characterizing Cutaneous Head and Neck Melanoma in Pediatric Patients: A
Retrospective Cohort Study.
J Am Acad Dermatol. 2025 Mar 17:S0190-9622(25)00448. PubMed
FRANKEL D, Valdes-Morales K, Trifoi MD, Lin SK, et al Mohs micrographic surgery reduces the risk of reconstruction with positive
margins, repeat surgeries, and time to definitive reconstruction compared to
conventional excision of hand and foot melanomas: a retrospective cohort study.
J Am Acad Dermatol. 2025 Mar 11:S0190-9622(25)00430. PubMedAbstract available
KUMAR AB, Jakub JW, Lester SC, Markovic SN, et al In-transit melanoma metastases: Evaluation and Management for the Dermatologist.
J Am Acad Dermatol. 2025 Mar 10:S0190-9622(25)00421. PubMedAbstract available
ELSTON DM Letter from the editor: Desmoplastic melanoma behaves differently from other
melanomas - American Joint Committee on Cancer staging should differ.
J Am Acad Dermatol. 2025 Mar 6:S0190-9622(25)00397. PubMed
JOSHI TP, Malhan P, Garcia N, Orengo IF, et al Melanoma-specific and overall survival in patients with single versus multiple
primary melanoma: a national database study.
J Am Acad Dermatol. 2025 Mar 3:S0190-9622(25)00391. PubMed
THOMAS KM, Treichel AM, Herrera HO, Cullison CR, et al Psychological impact of a cutaneous melanoma diagnosis: A retrospective
population-level cohort study.
J Am Acad Dermatol. 2025;92:605-607. PubMed
February 2025
HIJAZ BA, Braun N, Reynolds K, Semenov YR, et al Nivolumab/relatlimab-associated cutaneous immune-related adverse events in
patients treated for advanced melanoma: A multi-center retrospective cohort
study.
J Am Acad Dermatol. 2025 Feb 28:S0190-9622(25)00377. PubMed
CHANG CC, Lo SW, Chang HC, Song J, et al CTLA-4 inhibitors are associated with a higher risk of cardiovascular events than
PD-1 inhibitors in Patients with Melanoma.
J Am Acad Dermatol. 2025 Feb 27:S0190-9622(25)00370. PubMed
ARISTIZABAL MA, Evans LA, Pincelli TP, Degesys CA, et al Cutaneous Melanoma Trends and Disparities in Florida: A Decade of Incidence,
Mortality, and Workforce Data.
J Am Acad Dermatol. 2025 Feb 24:S0190-9622(25)00347. PubMed
RICARDO JW, Lipner SR Nail unit melanoma: Navigating patient and dermatologist worry Reply to "Melanoma
and Worry".
J Am Acad Dermatol. 2025 Feb 24:S0190-9622(25)00362. PubMed
GASEK N, Zhou AE, Gronbeck C, Jain NP, et al Minimally-invasive modalities for non-melanoma skin cancer Part II: Treatment.
J Am Acad Dermatol. 2025 Feb 21:S0190-9622(25)00320. PubMedAbstract available
CHEN J, Zhou Q Incorporating Regional Variability and Demographic Insights into Melanoma Public
Health Strategies.
J Am Acad Dermatol. 2025 Feb 17:S0190-9622(25)00308. PubMed
ZHANG H, Sun Y Reply: "Incorporating Regional Variability and Demographic Insights into Melanoma
Public Health Strategies".
J Am Acad Dermatol. 2025 Feb 17:S0190-9622(25)00309. PubMed
GIBSON FT, Ran NA, Schmults CD, Ruiz ES, et al Risk of metastasis at presentation and disease-specific death for desmoplastic
and spindle cell melanoma: a SEER database analysis.
J Am Acad Dermatol. 2025 Feb 5:S0190-9622(25)00194. PubMed
January 2025
VALDES MORALES KL, Frankel D, Trifoi MD, Lin SK, et al Nail Unit Melanoma Treated with Mohs Micrographic Surgery: Technique, Local
Recurrence Rate, and Surgical Outcomes.
J Am Acad Dermatol. 2025 Jan 21:S0190-9622(25)00102. PubMedAbstract available
THAKKER S, Jaguan D, Belzberg M, Gulati N, et al Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Clinical
Presentation, and Diagnosis.
J Am Acad Dermatol. 2025 Jan 8:S0190-9622(25)00011. PubMedAbstract available
JAGUAN D, Thakker S, Belzberg M, Gulati N, et al Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of
Systemic Therapy, Shortcomings and Future Directions.
J Am Acad Dermatol. 2025 Jan 7:S0190-9622(25)00012. PubMedAbstract available
December 2024
HEYMANN WR Melanoma and Worry.
J Am Acad Dermatol. 2024 Dec 19:S0190-9622(24)03373. PubMed
LIN S, Madan V, Joel MZ, Qiu C, et al Efficacy of shave (tangential) biopsies in melanoma diagnosis: A cross-sectional
study.
J Am Acad Dermatol. 2024 Dec 19:S0190-9622(24)03375. PubMed
ROHAN TZ, Mandel J, Banner L, Zachian R, et al The Risk of Developing Second Primary Malignancies in Cutaneous Melanoma
Survivors.
J Am Acad Dermatol. 2024 Dec 11:S0190-9622(24)03364. PubMed
SWERLICK RA, Li Y, Adamson AS Response to Taylor et al, "Enhanced disease-specific survival in lentigo maligna
melanoma patients treated with Mohs surgery over wide local excision: A
retrospective cohort analysis of the Surveillance, Epidemiology, and End Results
database".
J Am Acad Dermatol. 2024 Dec 6:S0190-9622(24)03333. PubMed
TOMSITZ D, Kerl K, French LE, Heinzerling L, et al Clinical and pathological characterization of tebentafusp-associated skin
toxicity: A cohort study with 33 patients.
J Am Acad Dermatol. 2024;91:1136-1142. PubMedAbstract available
November 2024
LAKE E JAAD Game Changers: "Pediatric melanomas often mimic benign skin lesions: A
retrospective study".
J Am Acad Dermatol. 2024 Nov 28:S0190-9622(24)03278. PubMed
KIM DY, Lin JY, Hartman RI Refusal of Surgery Among Cutaneous Melanoma Patients: Clinical Predictors and
Impacts on Melanoma-Specific Survival.
J Am Acad Dermatol. 2024 Nov 26:S0190-9622(24)03272. PubMed
SHAFIQUE N, Ertmann E, Tortorello G, Karakousis GC, et al Desmoplastic melanoma in the era of immune checkpoint blockade.
J Am Acad Dermatol. 2024 Nov 25:S0190-9622(24)03251. PubMed
TANG J, Cheng HR Insufficient evidence for association between dermatology follow-up and melanoma
survival.
J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03241. PubMed
HUANG Y, Fleming P, Fung K, Chan AW, et al Response to Tang et al., "Insufficient evidence for association between
dermatology follow-up and melanoma survival".
J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03240. PubMed
ROSENTHAL A, Kim JY, Juhasz ML, Conde G, et al Tumor Upstaging in Invasive Melanoma is Associated with Changes in Clinical
Management and Worse Prognosis.
J Am Acad Dermatol. 2024 Nov 21:S0190-9622(24)03233. PubMedAbstract available
TAYLOR MA, Sharma D, Thomas S, Wei EX, et al Reduced Disease-Specific Mortality in Melanoma in situ Patients Treated with Mohs
Surgery over Wide Local Excision: A Study of the Surveillance, Epidemiology, and
End Results Database.
J Am Acad Dermatol. 2024 Nov 20:S0190-9622(24)03225. PubMed
ZHANG Y, Wu J, Cai X, Jiang K, et al Nevus-associated acral melanoma has lower risk of recurrence and mortality than
de novo acral melanoma: A multicenter, retrospective analysis of 482 patients.
J Am Acad Dermatol. 2024 Nov 20:S0190-9622(24)03237. PubMedAbstract available
NEUBAUER ZJK, Lipner SR No association between Turner syndrome and melanoma risk: A retrospective cohort
study.
J Am Acad Dermatol. 2024 Nov 19:S0190-9622(24)03220. PubMed
KANTOR J This Month in JAAD International: February 2025: Melanoma biopsy approaches in
Australia and guidelines adherence.
J Am Acad Dermatol. 2024 Nov 19:S0190-9622(24)03229. PubMed
HEYMANN WR Turning Our Attention to Melanoma Risk in Turner Syndrome.
J Am Acad Dermatol. 2024 Nov 19:S0190-9622(24)03228. PubMed
AHMED A, Alani O, Haraldsdottir EL, Hoyt D, et al A Post-Pandemic Surge of Thick Melanomas in Women: A Nationwide Study on Skin
Cancer Incidence During COVID-19.
J Am Acad Dermatol. 2024 Nov 16:S0190-9622(24)03226. PubMed
ITUARTE BE, Taylor MA, Thomas SI, Sharma D, et al Clinical Presentations and Decreasing Incidence of Melanoma in Pediatric and AYA
Patients: 76,108 Cases from a Nationally Representative Cohort.
J Am Acad Dermatol. 2024 Nov 15:S0190-9622(24)03196. PubMedAbstract available
PATTERSON A JAAD Game Changers: "A single-institution assessment of superficial spreading
melanoma (SSM) in the pediatric population: Molecular and histopathologic
features compared with adult SSM".
J Am Acad Dermatol. 2024 Nov 14:S0190-9622(24)03206. PubMed
SKELSEY MK, Loftis B, Kaufmann MD, Siegel DM, et al Clinical Performance of a Noninvasive Melanoma Rule-Out Test Across Fitzpatrick
Skin Types.
J Am Acad Dermatol. 2024 Nov 14:S0190-9622(24)03157. PubMed
HIRNER JP, Rajeh A, Semenov YR, Kwatra SG, et al A retrospective cohort study of the time between prior antibiotics and checkpoint
inhibitors and association with survival in melanoma patients.
J Am Acad Dermatol. 2024 Nov 14:S0190-9622(24)03186. PubMed
TORTORELLO GN, Shafique N, Dheer A, Chu EY, et al Impact of 8(th) edition AJCC staging changes on sentinel lymph node biopsy
practices in melanoma.
J Am Acad Dermatol. 2024 Nov 13:S0190-9622(24)03158. PubMed
DANA IN, Kurtansky NR, Pastore LM, Xu JR, et al Differentiating Seborrheic Keratosis from Melanoma Among Lesions Exhibiting
Blue-White Veil: A Retrospective Study.
J Am Acad Dermatol. 2024 Nov 9:S0190-9622(24)03118. PubMedAbstract available
STULL CM, Clark D, Parker T, Idriss MH, et al Current and emerging intralesional immunotherapies in cutaneous oncology.
J Am Acad Dermatol. 2024;91:910-921. PubMedAbstract available
October 2024
SHARMA AN, Arora JS, Vidal NY, Demer AM, et al Tumor characteristics and outcomes of malignant melanomas on the genitalia.
J Am Acad Dermatol. 2024 Oct 22:S0190-9622(24)03028. PubMed
HUANG CT, Liao YH, Liau JY, Chu CY, et al Pretreatment neutrophil-to-lymphocyte ratio predicts survival in primary mucosal
melanoma.
J Am Acad Dermatol. 2024 Oct 22:S0190-9622(24)03026. PubMed
ALVAREZ GV, Liao KP, Wehner MR, Rogge MN, et al Melanoma risk in Turner Syndrome: a case-control study in SEER-Medicare.
J Am Acad Dermatol. 2024 Oct 9:S0190-9622(24)02961. PubMed
GONTIJO JRV, Nelson J, Diehl K, Korcheva VB, et al Thin and in situ melanomas of unfavorable prognosis: a retrospective
observational analysis of local recurrence, metastasis, and death in early-stage
disease.
J Am Acad Dermatol. 2024 Oct 8:S0190-9622(24)02964. PubMed
HO G, Collgros H, Sinz C, Melhoranse-Gouveia B, et al Remote cutaneous confocal microscopy: A multicentric prospective study evaluating
diagnostic accuracy for melanoma and keratinocyte carcinoma in tertiary settings.
J Am Acad Dermatol. 2024 Oct 8:S0190-9622(24)02956. PubMedAbstract available
MONCAYO AK, Grossman D, Kim CC, Hartman RI, et al Response to Bass et al's "Significant discordance in DermTech test results when
paired with histopathology: Caveat emptor".
J Am Acad Dermatol. 2024;91:e101-e102. PubMed
September 2024
SUN Y, Shen Y, Liu Q, Zhang H, et al Global Trends in Melanoma Burden: A Comprehensive Analysis from the Global Burden
of Disease Study, 1990-2021.
J Am Acad Dermatol. 2024 Sep 27:S0190-9622(24)02893. PubMedAbstract available
ZHANG Y, Chung J, Chen R, Malhotra S, et al Testing the ability of artificial intelligence chatbots and dermatologic
diagnosis mobile applications to diagnose melanoma and seborrheic keratosis.
J Am Acad Dermatol. 2024 Sep 24:S0190-9622(24)02882. PubMed
TAYLOR MA, Sharma D, Thomas SI, Ituarte BE, et al Examining Racial and Ethnic Disparities in Cutaneous Melanoma of the Head and
Neck.
J Am Acad Dermatol. 2024 Sep 15:S0190-9622(24)02829. PubMed
TAYLOR MA, Sharma D, Thomas S, Wei EX, et al Improved disease-specific survival in head and neck cutaneous melanomas treated
with Mohs surgery over wide local excision in the United States.
J Am Acad Dermatol. 2024 Sep 13:S0190-9622(24)02724. PubMed
LI AT, Xu JX, Blah TR, Lo SN, et al Comparison of clinicopathological features and treatment outcomes for cutaneous
melanomas of the head and neck and melanomas arising at other sites: implications
for systemic therapy.
J Am Acad Dermatol. 2024 Sep 5:S0190-9622(24)02768. PubMedAbstract available
GREEN LJ, Brouha B, Bhatia N Response to Bass et al's "Significant discordance in DermTech test results when
paired with histopathology: Caveat emptor".
J Am Acad Dermatol. 2024;91:e79. PubMed
August 2024
EVERDELL E, Borok J, Deutsch A, Ren Z, et al ATLAS: A positive, high-yield review of patient symptoms most significantly
associated with melanoma recurrence.
J Am Acad Dermatol. 2024 Aug 26:S0190-9622(24)02732. PubMedAbstract available
HOANG M, Mirza FN, Weinstock MA, Qureshi AA, et al Incidence of melanoma and its subtypes by census tract-level socioeconomic
status: a United States population-based cohort analysis.
J Am Acad Dermatol. 2024 Aug 23:S0190-9622(24)02729. PubMed
NUGENT S, Deitermann AM, Lin SK, Lewis DJ, et al Factors Associated with Adherence to Skin Self-examination Recommendations for
Melanoma Patients: A Prospective Cohort Study.
J Am Acad Dermatol. 2024 Aug 17:S0190-9622(24)02670. PubMed
SRIVASTAVA D Response to Bennett, "Correction to excision margins for melanoma in situ on the
head and neck".
J Am Acad Dermatol. 2024 Aug 16:S0190-9622(24)02663. PubMed
BENNETT R Correction to excision margins for melanoma in situ on the head and neck.
J Am Acad Dermatol. 2024 Aug 16:S0190-9622(24)02662. PubMed
WANG J, Hu G Boosting GPT-4V's Accuracy in Dermoscopic Classification with Few-Shot Learning.
Comment on "Can ChatGPT vision diagnose melanoma? An exploratory diagnostic
accuracy study(").
J Am Acad Dermatol. 2024 Aug 2:S0190-9622(24)02572. PubMed
July 2024
LATONI DI, Semenov YR, Tsao H Differential Time Series Analysis shows Decelerations in Melanoma Mortality Prior
to the Widespread Use of Highly Effective Therapies.
J Am Acad Dermatol. 2024 Jul 20:S0190-9622(24)02533. PubMedAbstract available
DACUNHA M, Tassavor M, South MB, Coldiron B, et al Improving Melanoma Reporting: The Ohio Model.
J Am Acad Dermatol. 2024 Jul 19:S0190-9622(24)02495. PubMed
FRIEDMAN A JAAD Game Changers: "Cutaneous adverse events (AEs) of anti-programmed cell death
(PD)-1 therapy in patients with metastatic melanoma: A single-institution
cohort".
J Am Acad Dermatol. 2024 Jul 17:S0190-9622(24)02501. PubMed
TUPPER CJ, Cogua LM, Silberstein PT Increasing Survival for Melanoma with Bony Metastases in the Era of Novel
Therapies: A Population-Based Retrospective Analysis.
J Am Acad Dermatol. 2024 Jul 16:S0190-9622(24)02493. PubMed
TAYE M, Machado KTL, Blalock T, Krueger LD, et al Differences in Skin Cancer Surveillance Among Patients with Non-melanoma Skin
Cancer by Race: A Retrospective Cohort Study.
J Am Acad Dermatol. 2024 Jul 6:S0190-9622(24)01036. PubMed
TAYLOR MA, Thomas SI, Fernandez JM, Wackel M, et al Enhanced Disease-Specific Survival in Lentigo Maligna Melanoma Patients Treated
with Mohs Surgery over Wide Local Excision: A Retrospective Cohort Analysis of
the Surveillance, Epidemiology, and End Results Database.
J Am Acad Dermatol. 2024 Jul 3:S0190-9622(24)00998. PubMed
June 2024
LAKE E JAAD Game Changers: "Functional surgery versus amputation for in situ or
minimally invasive nail melanoma: A meta-analysis".
J Am Acad Dermatol. 2024 Jun 29:S0190-9622(24)00983. PubMed
LAKE E JAAD Game Changers: "Melanoma-associated leukoderma and vitiligo cannot be
differentiated based on blinded assessment by experts in the field".
J Am Acad Dermatol. 2024 Jun 29:S0190-9622(24)00985. PubMed
JEAN-PIERRE P, Jacob Scheinkman R, Nouri K No significant disparities in non-melanoma skin cancer between Latino and White
cohorts in Miami, Florida: a single-center retrospective analysis.
J Am Acad Dermatol. 2024 Jun 22:S0190-9622(24)00954. PubMed
GRANT-KELS JM JAAD Game Changers: "Nevoid melanoma: A study of 43 cases with emphasis on growth
pattern".
J Am Acad Dermatol. 2024 Jun 14:S0190-9622(24)00923. PubMed
GRANT-KELS JM JAAD Game Changers: "Multiple primary melanomas among 16,570 patients with
melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011".
J Am Acad Dermatol. 2024 Jun 14:S0190-9622(24)00920. PubMed
UGWU N, Hawryluk EB, Weiss J Epidemiological Patterns and Survival Outcomes in 1,666 Cases of Malignant
Melanomas Arising from Giant Pigmented Nevi.
J Am Acad Dermatol. 2024 Jun 5:S0190-9622(24)00845. PubMed
May 2024
CHEN ML, Rezaei SJ, Kim J, Rodriguez C, et al Incidence of Suicide Among Melanoma and Non-Keratinocyte Skin Cancer Patients in
the US, 2000-2020.
J Am Acad Dermatol. 2024 May 18:S0190-9622(24)00787. PubMed
BRODELL RT JAAD Game Changers: "Screening, early detection, education, and trends for
melanoma: Current status (2007-2013) and future directions Part I. Epidemiology,
high-risk groups, clinical strategies, and diagnostic technology".
J Am Acad Dermatol. 2024 May 18:S0190-9622(24)00795. PubMed
SHAH P, Trepanowski N, Grant-Kels JM, LeBoeuf M, et al Mohs Micrographic Surgery in the Surgical Treatment Paradigm of Melanoma In Situ
and Invasive Melanoma: A Clinical Review of Treatment Efficacy and Ongoing
Controversies.
J Am Acad Dermatol. 2024 May 18:S0190-9622(24)00756. PubMedAbstract available
FREEMAN SC, Paz Munoz E, Latour E, Lim JY, et al Response to Prieto et al., "RE: External validation of the Melanoma Institute
Australia Sentinel Lymph Metastasis Risk Prediction Tool using the National
Cancer Database".
J Am Acad Dermatol. 2024 May 11:S0190-9622(24)00733. PubMed
PRIETO PA, Goldberg MS, Martin B RE: External validation of the Melanoma Institute Australia Sentinel Lymph
Metastasis Risk Prediction Tool using the National Cancer Database.
J Am Acad Dermatol. 2024 May 9:S0190-9622(24)00735. PubMed
April 2024
KOGA S, Du W, Ono D Response to "Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic
Accuracy Study.".
J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00671. PubMed
DESAI AD, Ibrahim SJ, Samie FH Evaluating the benefit of immunotherapy for Stage III melanoma.
J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00679. PubMed
MONNIER J, Gouabou Foahom AC, Serdi M, Collenne J, et al Automated melanoma detection. An algorithm inspired from human intelligence
characterizing disordered pattern of melanocytic lesions improving a
convolutional neural network.
J Am Acad Dermatol. 2024 Apr 11:S0190-9622(24)00630. PubMed
WANG E, Ahad T, Liu YA, Lee TK, et al Incidence and profile of skin cancers in patients following ultraviolet
phototherapy without psoralens: A retrospective cohort study.
J Am Acad Dermatol. 2024;90:759-766. PubMedAbstract available
COHEN Y, Jaberi M, Litvinov IV, Shamout Y, et al Novel suturing technique for reduced electrocautery in excisional procedures for
non-melanoma skin cancer.
J Am Acad Dermatol. 2024;90:e131-e132. PubMed
March 2024
FUNCHAIN P, Ni Y, Heald B, Bungo B, et al Germline Cancer Susceptibility in Individuals with Melanoma.
J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00504. PubMedAbstract available
BANNER L, Rohan TZ, Zachian R, Gross T, et al Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate
cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database
analysis.
J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505. PubMed
MATTHEWS NH, Hamad J, Henderson JB, Weinstock MA, et al Projected burden of melanoma clinical surveillance in the United States.
J Am Acad Dermatol. 2024 Mar 8:S0190-9622(24)00476. PubMed
TUPPER CJ, Clausen MC, Cogua LM, Silberstein PT, et al Improved Survival Outcomes for Melanoma of Unknown Primary in the Era of Novel
Therapies: A Population-Based Retrospective Analysis.
J Am Acad Dermatol. 2024 Mar 6:S0190-9622(24)00446. PubMed
NEALE H, Plumptre I, Belazarian L, Wiss K, et al Guidance on screening magnetic resonance imaging decisions for congenital
melanocytic nevi.
J Am Acad Dermatol. 2024;90:e107-e108. PubMed
GRANT-KELS JM JAAD Game Changer: Clinical and dermoscopic features of cutaneous
BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study
by the International Dermoscopy Society.
J Am Acad Dermatol. 2024;90:674. PubMed
February 2024
GIULINI M, Goldust M, Grabbe S, Ludwigs C, et al Combining artificial intelligence and human expertise for more accurate
dermoscopic melanoma diagnosis: A 2-session retrospective reader study.
J Am Acad Dermatol. 2024 Feb 29:S0190-9622(24)00307. PubMed
TORTORELLO GN, Li EH, Sharon CE, Shafique N, et al Pathologic Characteristics and Clinical Outcomes of Primary Dermal Melanoma.
J Am Acad Dermatol. 2024 Feb 22:S0190-9622(24)00401. PubMed
HUANG Y, Fleming P, Fung K, Chan AW, et al Association between dermatology follow-up and melanoma survival: a
population-based cohort study.
J Am Acad Dermatol. 2024 Feb 16:S0190-9622(24)00372. PubMedAbstract available
MORR C, Jade Prechtel T, Hardacker R, Bell M, et al Impact of skin cancer screening on melanoma thickness and stage.
J Am Acad Dermatol. 2024 Feb 13:S0190-9622(24)00348. PubMed
KYE Y, Zhao G, Guhan S, Nunes D, et al Research letter: BRAF-inhibitor induced panniculitis - A systematic review.
J Am Acad Dermatol. 2024;90:420-423. PubMed
January 2024
KOOPER-JOHNSON S, Kasthuri V, Homer A, Nguyen BM, et al Higher Risk of Melanoma-related Deaths for Patients Residing in Rural Counties: A
Surveillance, Epidemiology, and End Results Program Study.
J Am Acad Dermatol. 2024 Jan 31:S0190-9622(24)00167. PubMed
CHOI ME, Jung JM, Kim DH, Won CH, et al Baseline Serum Neutrophil-to-Lymphocyte Ratio in Acral Melanoma Compared to
Non-Acral Melanoma and its Prognostic Significance.
J Am Acad Dermatol. 2024 Jan 23:S0190-9622(24)00103. PubMedAbstract available
TATE JA, Matsumoto A, Greif C, Lim J, et al Excision Margins for Melanoma in Situ on the Head and Neck - A Single-Center
10-year Retrospective Review of Treatment with Mohs Micrographic Surgery.
J Am Acad Dermatol. 2024 Jan 20:S0190-9622(24)00102. PubMedAbstract available
SHIFAI N, van Doorn R, Malvehy J, Sangers T, et al Can ChatGPT Vision Diagnose Melanoma? An Exploratory Diagnostic Accuracy Study.
J Am Acad Dermatol. 2024 Jan 18:S0190-9622(24)00076. PubMed
VIKSTROM S, Syriopoulou E, Andersson TM, Eriksson H, et al Loss in life expectancy in Patients with Stage II-III cutaneous melanoma in
Sweden: a population-based cohort study.
J Am Acad Dermatol. 2024 Jan 11:S0190-9622(24)00056. PubMedAbstract available
TIMURKAYNAK O, Gonenli G Response to Young JN et al.'s "The utility of ChatGPT in generating
patient-facing and clinical responses for melanoma".
J Am Acad Dermatol. 2024 Jan 10:S0190-9622(24)00060. PubMed
HEKLER A, Maron RC, Haggenmuller S, Schmitt M, et al Using Multiple Real-World Dermoscopic Photographs of One Lesion Improves Melanoma
Classification via Deep Learning.
J Am Acad Dermatol. 2024 Jan 8:S0190-9622(24)00048. PubMed
NAVARRETE-DECHENT C, Jaimes N, Dusza SW, Liopyris K, et al Perifollicular linear projections: A dermatoscopic criterion for the diagnosis of
lentigo maligna on the face.
J Am Acad Dermatol. 2024;90:52-57. PubMedAbstract available
December 2023
BERK-KRAUSS J, Sharma M, Polsky D, Geller AC, et al Cutaneous Melanoma Incidence - Evidence of a Flattening Curve.
J Am Acad Dermatol. 2023 Dec 10:S0190-9622(23)03288. PubMed
HAGSTROM M, Dhillon S, Fumero-Velazquez M, Olivares S, et al A reappraisal of the epidemiology of Spitz neoplasms in the molecular era:
A retrospective cohort study.
J Am Acad Dermatol. 2023;89:1185-1191. PubMedAbstract available
KOOPER-JOHNSON SB, Weber M, Eichtadt S, Nguyen BM, et al Limited commercialization of artificial intelligence technology in the diagnosis
of pigmented lesions despite explosive growth in published programs.
J Am Acad Dermatol. 2023;89:1246-1248. PubMed
WAGNER NB, Knierim SM, Luttermann F, Metzler G, et al Histopathologic regression in patients with primary cutaneous melanoma undergoing
sentinel lymph node biopsy is associated with favorable survival and, after
metastasis, with improved progression-free survival on immune checkpoint
inhibitor therapy: A
J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03250. PubMedAbstract available
FERNANDEZ JM, Mata EM, Plampton K, Whitley MJ, et al Melanoma Characteristics and Overall Survival Predictors in American Indians and
Alaska Natives: An Analysis of the National Cancer Database from 2004 to 2018.
J Am Acad Dermatol. 2023 Dec 1:S0190-9622(23)03254. PubMed
November 2023
FERNANDEZ JM, Evans TD, Schissel M, Siller A Jr, et al Racial and ethnic differences in time to definitive surgery for melanoma: A
retrospective study from the National Cancer Database.
J Am Acad Dermatol. 2023 Nov 30:S0190-9622(23)03251. PubMed
PAN CX, Liu M, Lau CB, Lau WC, et al Histopathological predictors of immune-related adverse events among patients with
melanoma treated with immune checkpoint inhibitors.
J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03239. PubMed
HAWRYLUK EB, Moustafa D, Barry KK, Bahrani E, et al Risk Factors and Outcomes of Melanoma in Children and Adolescents: A
Retrospective Multicenter Study.
J Am Acad Dermatol. 2023 Nov 29:S0190-9622(23)03238. PubMedAbstract available
FALDETTA C, Kaleci S, Chester J, Ruini C, et al Melanoma clinicopathological groups characterized and compared with dermoscopy
and reflectance confocal microscopy.
J Am Acad Dermatol. 2023 Nov 19:S0190-9622(23)03014. PubMedAbstract available
MAGHFOUR J, Li P, Piontkowski A, Ozog D, et al Melanoma Incidence and Mortality: Exploring the Impact of Regional UV Radiation
and Socioeconomic Status in the Context of Breslow Thickness.
J Am Acad Dermatol. 2023 Nov 8:S0190-9622(23)03181. PubMed
CLARK P, Howard H, Garrett E, Waters P, et al Health inequities in melanoma: A scoping review.
J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)02892. PubMed
KIM DY, Swetter SM, Huhmann L, Dizon MP, et al Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors
among Veteran cutaneous melanoma patients.
J Am Acad Dermatol. 2023 Nov 2:S0190-9622(23)03089. PubMed
TOMAS-VELAZQUEZ A, Lopez-Gutierrez JC, Reyes-Mugica M, Salgado CM, et al Serum levels of S-100 protein are directly proportional to the size, number,
thickness and degree of cellularity of congenital melanocytic nevi.
J Am Acad Dermatol. 2023;89:1074-1077. PubMed
AHMED F, Fisher MJ, Snyder KM, Smith K, et al Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric
population.
J Am Acad Dermatol. 2023;89:1066-1068. PubMed
KIM DY, Christopher Dee E, Cheng I, Hartman RI, et al Advanced melanoma presentation and disease-specific survival disparities among
disaggregated Asian American, Native Hawaiian, and Pacific Islander populations.
J Am Acad Dermatol. 2023 Nov 1:S0190-9622(23)03090. PubMed
October 2023
RAVICHANDRAN S, Briskin I, Arbesman J Increased diagnostic interval for nodular melanomas does not associate with
increased tumor thickness or staging: results from a single-center retrospective
chart review.
J Am Acad Dermatol. 2023 Oct 28:S0190-9622(23)03088. PubMed
EVERDELL E, Shah H, Parisi R, Feustel PJ, et al Non-visibility of Suspicious Lesions by Patients Leads to Later Detection of
Melanoma: A Retrospective Analysis.
J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02888. PubMed
FERNANDEZ JM, Koblinski JE, Dahak S, Curiel-Lewandrowski C, et al Gender Differences in Pediatric and Adolescent Melanoma: A Retrospective Analysis
of 4,645 Cases.
J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02866. PubMedAbstract available
WAN G, Leung BW, DeSimone MS, Nguyen N, et al Development and Validation of Time-to-Event Models to Predict Metastatic
Recurrence of Localized Cutaneous Melanoma.
J Am Acad Dermatol. 2023 Oct 3:S0190-9622(23)02881. PubMedAbstract available
YUMEEN S, Mirza FN, Mirza HN, Zogg CK, et al Malignant blue nevus: Characterization of US epidemiology and prognostic factors
of a rare neoplasm with aggressive clinical course using the Surveillance,
Epidemiology, and End Results Program database.
J Am Acad Dermatol. 2023;89:843-846. PubMed
KRENGEL S, Ott H, Waelchli R Recommendations for routine magnetic resonance imaging in children with
congenital melanocytic nevi need revision Comment to Neale et al., J Am Acad
Dermatol. 87(5):1060-1068.
J Am Acad Dermatol. 2023;89:e153-e154. PubMed
September 2023
WEI AH, Fane LS, Tripathi R, Bordeaux JS, et al Differences in presentation of cutaneous melanoma among Asian American and
Pacific Islander patients.
J Am Acad Dermatol. 2023 Sep 26:S0190-9622(23)02868. PubMed
WEI AH, Zheng DX, Cullison CR, Scott JF, et al Incidence and characteristics of acral lentiginous melanoma in Asian Americans
and Pacific Islanders.
J Am Acad Dermatol. 2023 Sep 19:S0190-9622(23)02828. PubMed
TAN SX, Aung TN, Claeson M, Acs B, et al Automated scoring of tumour infiltrating lymphocytes informs risk of death from
thin melanoma: a nested case-case study.
J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02833. PubMed
NI Y, Watts CG, Scolyer RA, Madronio C, et al Prognosis for people with multiple primary melanomas compared with a single
primary melanoma.
J Am Acad Dermatol. 2023 Sep 13:S0190-9622(23)02693. PubMed
WU Q, Pan J, Lin W, Zhao S, et al Clinicopathologic features, delayed diagnosis and survival in amelanotic acral
melanoma: a comparative study with pigmented melanoma.
J Am Acad Dermatol. 2023 Sep 8:S0190-9622(23)02677. PubMed
LIN JY, Wang J, Mishra K, Osmani S, et al Non-Melanoma Skin Cancer in Skin of Color Solid Organ Transplant Recipients.
J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02678. PubMed
GRANT-KELS JM JAAD Game Changers: Poor prognosis for thin ulcerated melanomas and implications
for a more aggressive approach to treatment.
J Am Acad Dermatol. 2023 Sep 7:S0190-9622(23)02674. PubMed
JILANI S, D'Amiano NM, Thompson KG, Ellis J, et al Factors Affecting Follow-Up Adherence Following Mohs Micrographic Surgery in
Patients with Non-Melanoma Skin Cancer: A Retrospective Chart Review.
J Am Acad Dermatol. 2023 Sep 5:S0190-9622(23)02669. PubMed
KIM U, Hoehn R, Schwartz GK, Cullen J, et al Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic
from a community-based perspective.
J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02659. PubMed
COSTELLO CM, Dusza SW, Marghoob AA, Halpern AC, et al Melanoma Screening and Public Education for Minority Populations in the United
States.
J Am Acad Dermatol. 2023 Sep 2:S0190-9622(23)02663. PubMed
ANVERY N, Kang B, Christensen RE, Dirr MA, et al Minimum thresholds deemed acceptable by patients and physicians for sensitivity
and specificity of mobile skin cancer screening algorithms.
J Am Acad Dermatol. 2023;89:595-597. PubMed
CHOI S, Mulvaney P Evaluating the landscape of discount and patient assistance programs for topical
sunscreen products in the United States.
J Am Acad Dermatol. 2023;89:580-582. PubMed
August 2023
SORENSEN R Impact of scalp location on survival in head and neck melanoma: A retrospective
cohort study.
J Am Acad Dermatol. 2023 Aug 26:S0190-9622(23)02633. PubMed
XIONG DD, Bordeaux J The impact of the COVID-19 pandemic in 2020 on the diagnosis, treatment, and
outcomes of invasive cutaneous melanoma: a retrospective national cohort study.
J Am Acad Dermatol. 2023 Aug 23:S0190-9622(23)02595. PubMedAbstract available
BRODELL RT Primary dermal melanoma: A unique subtype of melanoma to be distinguished from
cutaneous metastatic melanoma: A clinical, histologic, and gene
expression-profiling study.
J Am Acad Dermatol. 2023 Aug 16:S0190-9622(23)02515. PubMed
ROSTER K, Rajeh A, Wu F, Wan G, et al Recurrence and Survival in Early-stage Acral Lentiginous Melanoma, A
Retrospective Analysis.
J Am Acad Dermatol. 2023 Aug 13:S0190-9622(23)02494. PubMed
PAN CX, Lau WC, Kim DY, Lau CB, et al Association between baseline lactate dehydrogenase and immune-related adverse
events among patients with melanoma varies by tumor stage at immune checkpoint
inhibitor initiation.
J Am Acad Dermatol. 2023 Aug 8:S0190-9622(23)02422. PubMed
EL SHAROUNI MA, Lo SN, Scolyer RA, van Gils CH, et al Reply to: "Estrogen could also play a key role in the development of pediatric
melanoma".
J Am Acad Dermatol. 2023;89:e97-e98. PubMed
July 2023
AMARAL T, Pop OT, Chatziioannou E, Sinnberg T, et al EGFR expression is associated with relapse in a melanoma cohort receiving
adjuvant PD-1-based immunotherapy.
J Am Acad Dermatol. 2023 Jul 22:S0190-9622(23)02392. PubMed
FREEMAN SC, Munoz EP, Latour E, Lim JY, et al External validation of the Melanoma Institute Australia Sentinel Node Metastasis
Risk Prediction Tool using the National Cancer Database.
J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01350. PubMedAbstract available
HOANG MP, Karpinski P, Zuniga-Castillo M, Foreman RK, et al Histologic Margin Status is a Predictor of Relapse in Lentigo Maligna Melanoma.
J Am Acad Dermatol. 2023 Jul 14:S0190-9622(23)01349. PubMedAbstract available
UGWU N, Cheraghlou S, Weiss J Primary Merkel Cell Carcinoma Is Associated with Increased, Extended Risk of
Subsequent Melanoma and Non-Epithelial Skin Cancer.
J Am Acad Dermatol. 2023 Jul 12:S0190-9622(23)01345. PubMed
FERNANDEZ JM, Mata EM, Bubic BN, Kwan KR, et al Racial and ethnic differences in males with melanoma: A retrospective cohort
study of 205,125 cases from the National Cancer Database.
J Am Acad Dermatol. 2023 Jul 11:S0190-9622(23)01105. PubMed
MUNOZ EP, Patel SP, Leachman SA, Yu NY, et al Minority Enrollment in Melanoma Clinical Trials.
J Am Acad Dermatol. 2023 Jul 5:S0190-9622(23)01263. PubMed
MEVES A, Todd A, Johnson EF Tumor width and calculated tumor area do not outperform Breslow thickness in
predicting sentinel lymph node biopsy positivity.
J Am Acad Dermatol. 2023;89:188-190. PubMed
SMITH B, Smith JE, Demanelis K, Ferris LK, et al Changes in skin cancer screening rates in the United States from 2005 to 2015.
J Am Acad Dermatol. 2023;89:142-145. PubMed
MORGAN FC, Yehia L, McDonald C, Martinez-Agosto JA, et al Characterizing dermatologic findings among patients with PTEN hamartoma tumor
syndrome: Results of a multicenter cohort study.
J Am Acad Dermatol. 2023;89:90-98. PubMedAbstract available
June 2023
INGRASSIA JP, Adotama P, Stein JA, Polsky D, et al Re-examining melanoma secondary prevention and the role of skin self-examination.
J Am Acad Dermatol. 2023 Jun 27:S0190-9622(23)01195. PubMed
RYPKA KJ, Goldfarb N, Mansh M Response to the Feasibility of Kreher et al.'s "Risk of melanoma and nonmelanoma
skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents,
biologics, and small molecule inhibitors".
J Am Acad Dermatol. 2023 Jun 26:S0190-9622(23)01188. PubMed
PAN CX, Nambudiri VE Response to: "Response to Pan et al.'s 'Non-melanoma skin cancer in patients with
hereditary hemochromatosis: a case-control study.'".
J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01099. PubMed
BARRY R, Murray G, Hazel K, Ryan J, et al Response to Pan et al.'s "Non-melanoma skin cancer in patients with hereditary
hemochromatosis: a case-control study.".
J Am Acad Dermatol. 2023 Jun 12:S0190-9622(23)01100. PubMed
ABRANTES T, Robbins A, Kahn B, Yumeen S, et al Understanding melanoma in situ - lentigo maligna surgical treatment terminology
and guideline adherence, a targeted review.
J Am Acad Dermatol. 2023 Jun 10:S0190-9622(23)01084. PubMedAbstract available
CHANG ALS, Zaba L, Kwong BY Immunotherapy for keratinocyte cancers. Part II: Identification and management of
cutaneous side effects of immunotherapy treatments.
J Am Acad Dermatol. 2023;88:1243-1255. PubMedAbstract available
LEUNG BW, Wan G, Nguyen N, Rashdan H, et al Increased risk of cutaneous immune-related adverse events in patients treated
with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital
cohort study.
J Am Acad Dermatol. 2023;88:1265-1270. PubMedAbstract available
May 2023
LIM RK, Weinstock MA Racial disparities in diagnosis of invasive melanoma among veterans: A
comparative analysis with the Surveillance, Epidemiology, and End Results
Program.
J Am Acad Dermatol. 2023 May 29:S0190-9622(23)00985. PubMed
RAJEH A, Wan G, Roster K, Rashdan H, et al Underuse of sentinel lymph node biopsy for early-stage melanoma.
J Am Acad Dermatol. 2023 May 25:S0190-9622(23)00975. PubMed
KO MJ, Tsai WC, Tsai PH, Hsu LY, et al Ultraviolet B Phototherapy Does Not Increase the Risk of Skin Cancer Among
Patients with Atopic Dermatitis: A Population-Based Retrospective Cohort Study.
J Am Acad Dermatol. 2023 May 24:S0190-9622(23)00977. PubMedAbstract available
HEERFORDT IM, Philipsen PA, Andersen JD, Langhans L, et al RNA analysis of tape strips to rule out melanoma in lesions clinically assessed
as cutaneous malignant melanoma: A diagnostic study.
J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00971. PubMedAbstract available
FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al Asian American and Pacific Islander patients with melanoma have increased odds of
treatment delays: a cross-sectional study.
J Am Acad Dermatol. 2023 May 22:S0190-9622(23)00969. PubMedAbstract available
KIM DY, Marchetti MA, Hartman RI Differences in thickness-specific incidence of cutaneous melanoma by county type
in the United States, 2010-2019.
J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00905. PubMed
YOUNG JN, O'Hagan R, Poplausky D, Levoska MA, et al The utility of ChatGPT in generating patient-facing and clinical responses for
melanoma.
J Am Acad Dermatol. 2023 May 17:S0190-9622(23)00908. PubMed
ZHANG S, Tang K, Wan G, Nguyen N, et al Cutaneous immune-related adverse events are associated with longer overall
survival in advanced cancer patients on immune checkpoint inhibitors: A
multi-institutional cohort study.
J Am Acad Dermatol. 2023;88:1024-1032. PubMedAbstract available
JOEL MZ, Tripathi R, Scott JF Predictors of receipt of sentinel lymph node biopsy in patients with malignant
adnexal tumors of the skin.
J Am Acad Dermatol. 2023;88:1179-1182. PubMed
FELMINGHAM C, Pan Y, Kok Y, Kelly J, et al Improving skin cancer management with ARTificial intelligence: A pre-post
intervention trial of an artificial intelligence system used as a diagnostic aid
for skin cancer management in a real-world specialist dermatology setting.
J Am Acad Dermatol. 2023;88:1138-1142. PubMed
SHI K, Zhang B, Kong BY, Zhang Y, et al Distinct genomic features in a retrospective cohort of mucosal, acral, and
vulvovaginal melanomas.
J Am Acad Dermatol. 2023;88:1051-1059. PubMedAbstract available
CAI ED, Swetter SM, Sarin KY Association of multiple primary melanomas with malignancy risk: A
population-based analysis of entries from the Surveillance, Epidemiology, and End
Results program database during 1973-2014.
J Am Acad Dermatol. 2023;88:e211-e219. PubMedAbstract available
April 2023
AZOULAY L, St-Jean A, Dahl M, Quail J, et al Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A
multi-site population-based cohort study.
J Am Acad Dermatol. 2023 Apr 25:S0190-9622(23)00735. PubMedAbstract available
SHANNON AB, Karakousis GC The impact of the COVID-19 pandemic on new diagnoses of melanoma: a response to
additional multi-institution and international reports.
J Am Acad Dermatol. 2023 Apr 22:S0190-9622(23)00732. PubMed
DRUMM C, Griffin C, Van Baarsel S, Quigley C, et al Response to Trepanowski et al.'s "Delays in melanoma presentation during the
COVID-19 pandemic: a nationwide multi-institutional cohort study".
J Am Acad Dermatol. 2023 Apr 21:S0190-9622(23)00733. PubMed
CHOI ME, Yang HJ, Won CH, Chang SE, et al Differences in the Tumor Immunity-related Gene Expression Profile Between Acral
Lentiginous and Non-acral Melanoma.
J Am Acad Dermatol. 2023 Apr 19:S0190-9622(23)00712. PubMed
FANE LS, Wei AH, Tripathi R, Bordeaux JS, et al Disparities between Asian groups in time to melanoma treatment: a cross-sectional
study.
J Am Acad Dermatol. 2023 Apr 11:S0190-9622(23)00589. PubMed
HARVEY JA, Smith JF, Berry NA, Butterfield RJ, et al The influence of dermoscopy education over 14 years at a single institution: A
retrospective cohort study.
J Am Acad Dermatol. 2023;88:906-908. PubMed
March 2023
CRUM OM, Campbell EH, Reinhart JP, Proffer SL, et al Incidence Trends of Melanoma among Young Adults: An Epidemiologic Study in
Olmsted County, Minnesota.
J Am Acad Dermatol. 2023 Mar 29:S0190-9622(23)00518. PubMed
MATA EM, Trinidad N, Blue E, Lobl M, et al Disparities in melanoma outcomes in urban versus rural settings: An analysis from
the Nebraska Cancer Registry 2001-2016.
J Am Acad Dermatol. 2023 Mar 20:S0190-9622(23)00450. PubMed
MAGNATERRA E, Zuccaro B, Magliulo M, Venturi F, et al Estrogen could also play a key role in the development of pediatric melanoma.
J Am Acad Dermatol. 2023 Mar 18:S0190-9622(23)00439. PubMed
LIN EM, Lim RK, Lin S, Cho E, et al Disparities in Asian American Melanoma Diagnosis and Treatment from 1990-2014 --
Response to Zheng et al. "Poor melanoma outcomes and survival in Asian American
and Pacific Islander patients".
J Am Acad Dermatol. 2023 Mar 9:S0190-9622(23)00357. PubMed
KIM DY, Behbahani S, Hartman RI Impact of COVID-19 pandemic on melanoma presentation by facility type and region
in the United States.
J Am Acad Dermatol. 2023 Mar 8:S0190-9622(23)00356. PubMed
VERMARIEN-WANG J, Doeleman T, van Doorn R, Mooyaart AL, et al Ambiguous melanocytic lesions: A retrospective cohort study of incidence and
outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and
superficial atypical melanocytic proliferation of uncertain significance (SAMPUS)
in the Netherlan
J Am Acad Dermatol. 2023;88:602-608. PubMedAbstract available
TARANTINO IS, Kwak YJ, Goldberg LH, Beroukhim K, et al Application of a taped gauze on the gloved hand in preparation for a pressure
bandage after a Mohs micrographic surgery layer.
J Am Acad Dermatol. 2023;88:e125-e126. PubMed
LEE K JAAD Game Changers *: The association of indoor tanning and melanoma in adults:
Systematic review and meta-analysis.
J Am Acad Dermatol. 2023;88:749. PubMed
February 2023
IQBAL A, Bell MC, Merkel EA, Somani AK, et al The effect of tumor mitotic rate on melanoma-specific survival: A SEER
population-based study of 54,598 cases.
J Am Acad Dermatol. 2023 Feb 23:S0190-9622(23)00274. PubMed
NGUYEN N, Wan G, Ugwu-Dike P, Alexander NA, et al Influence of melanoma type on incidence and downstream implications of cutaneous
immune-related adverse events in the setting of immune checkpoint inhibitor
therapy.
J Am Acad Dermatol. 2023 Feb 22:S0190-9622(23)00204. PubMedAbstract available